BVMF/DASA3 (BVMF/DASA3)

Brazil Stock Exchange: BVMF/DASA3 · BRL

R$2.98

-0.19 (-6.0%)· Recorded snapshot

Market cap	3.7B
Revenue (ttm)	9.3B
Net income (ttm)	-895.1M
EPS (ttm)	-R$0.71
Shares out	1.2B
P/E (forward)	16.8x
Volume	1,918,100
Beta	0.24

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 9.3B
Net income (ttm): -895.1M
EPS (ttm): -R$0.71
P/E (forward): 16.8x
Market cap: 3.7B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/E16.8

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-12.1

P25 n/aP50 n/aP75 n/a

ROIC7.8

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BVMF/DASA3 indicators

Market & fundamental data

Available fields

228

Groups with data

Currency

BRL

Showing 228 of 228 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	BRL
Country	Brazil
Country code	BR
Earnings date	2026-11-05
Employees	26,255
Employees change	-21,745
Employees growth	-45.3%
Enterprise value	BRL 10.5B
Exchange	Brazil Stock Exchange
Financial currency	BRL
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1961
Industry	Diagnostics & Research
Is primary listing	Yes
ISIN number	BRDASAACNOR1
Last earnings date	2026-08-13
Last refreshed	2026-10-29
Last stock split date	2010-02-02
Last stock split type	Forward
Market cap	BRL 3.7B
Next earnings date	2026-11-05
Price	BRL 2.98
Price currency	BRL
Sector	Healthcare
SIC code	8071
Stock price date	2026-10-29
Symbol	bvmf/DASA3
Website	https://www.dasa3.com.br

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-23.88%
EV/EBIT	10.54x
EV/EBITDA	6.22x
EV/FCF	44.85x
EV/Sales	1.15x
FCF / EV yield	2.23%
FCF yield	6.02%
Forward P/E	16.77x
P/(FCF - SBC) ratio	17.82x
P/(OCF - SBC) ratio	9.45x
P/B ratio	0.58x
P/FCF ratio	16.61x
P/OCF ratio	9.09x
P/S ratio	0.42x
PEG ratio	0.15x
Price / tangible book value	1.53x
Price/EBITDA ratio	2.68x
Sector forward P/E	11.33x
Sector P/E	41.97x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	11.3%
EBITDA margin	15.85%
FCF margin	2.56%
Gross margin	31.02%
Operating margin	11.3%
Pretax margin	-7.48%
Profit margin	-9.6%
Profit per employee	BRL -34,093
Revenue per employee	BRL 355,151
ROA	3.53%
ROA (5Y)	2.08%
ROCE	7.69%
ROE	-12.09%
ROE (5Y)	-11.17%
ROIC	7.75%
ROIC (5Y)	4.8%
SBC / revenue	0.17%
Tax / revenue	1.92%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	2
EPS growth years	2
FCF growth 5Y	14.15%
Gross profit growth	-24.99%
Gross profit growth (Q)	-15.23%
Gross profit growth 3Y	-10.59%
Gross profit growth 5Y	0.79%
Net income growth quarters	2
Net income growth years	1
OCF growth 10Y	-3.53%
OCF growth 5Y	-7.07%
Operating income growth	12.59%
Operating income growth (Q)	61.61%
Operating income growth 3Y	-1.75%
Operating income growth 5Y	72.9%
Revenue growth	-33.07%
Revenue growth (Q)	-9.83%
Revenue growth (QoQ)	0.03%
Revenue growth 10Y	12.39%
Revenue growth 3Y	-12.4%
Revenue growth 5Y	0.1%
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	BRL -197M
Depreciation and amortization	BRL 424.6M
EBIT	BRL 1.1B
EBITDA	BRL 1.5B
EPS	BRL -0.71
FCF per share	BRL 0.19
Financing cash flow	BRL -2.3B
Free cash flow	BRL 238.6M
Free cash flow minus SBC	BRL 222.4M
Gross profit	BRL 2.9B
Income taxes	BRL 179.4M
Investing cash flow	BRL 1.5B
Net borrowing	BRL -2B
Net cash flow	BRL -387M
Net income	BRL -895.1M
Operating cash flow minus SBC	BRL 419.4M
Operating income	BRL 1.1B
Revenue	BRL 9.3B
Stock-based compensation	BRL 16.2M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	0.67
Book value per share	BRL 5.47
Debt / EBITDA	4.36
Debt / equity	1.12
Debt / FCF	32.16
Goodwill	BRL 3.4B
Interest coverage	0.85
Long-term assets	BRL 12.8B
Long-term liabilities	BRL 6.8B
Net cash (debt)	BRL -6.7B
Net cash / market cap	-169.45%
Net debt / EBITDA	4.54
Net debt / equity	0.98
Net debt / FCF	28.14
Piotroski F-Score	5
Property, plant and equipment	BRL 2.6B
Shareholders' equity	BRL 6.9B
Tangible book value	BRL 2.6B
Tangible book value per share	BRL 2.08
Total assets	BRL 17.1B
Total cash	BRL 958.7M
Total debt	BRL 7.7B
Total liabilities	BRL 10.3B
WACC	10.37%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.5
Current assets	BRL 4.4B
Current liabilities	BRL 3.4B
Current ratio	1.27
Inventory turnover	29.71
Net working capital	BRL 1.6B
Quick ratio	1.22
Working capital	BRL 921.1M
Working capital turnover	7.79

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	16.2%
Dividend growth (10Y)	2.85%
Dividend growth (3Y)	-18.73%
Dividend growth (5Y)	24.57%
Dividend per share	BRL 0.00
Last dividend	BRL 0.30
Shareholder yield	16.2%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-84.74%
10Y return CAGR	-16.7%
10Y total return	-83.92%
150-day SMA	BRL 3.12
15Y price change	-78.87%
15Y return CAGR	-9.38%
15Y total return	-77.18%
1D price change	-5.99%
1M price change	-18.53%
1M total return	-18.53%
1W price change	-44.63%
1W total return	-44.63%
1Y price change	79.04%
1Y return CAGR	79.11%
1Y total return	79.04%
20-day SMA	BRL 4.49
200-day SMA	BRL 3.33
20Y price change	-73.66%
20Y return CAGR	-5.99%
20Y total return	-70.95%
3M price change	12.83%
3M total return	12.83%
3Y price change	-69.64%
3Y return CAGR	-32.79%
3Y total return	-69.64%
50-day SMA	BRL 3.54
50-day SMA vs 200-day SMA	50over200
52-week high	BRL 5.79
52-week high date	2026-10-21
52-week low	BRL 1.56
52-week low date	2025-11-04
5Y price change	-91.6%
5Y return CAGR	-38.97%
5Y total return	-91.53%
6M price change	-6.56%
6M total return	-6.56%
All-time high	BRL 242.00
All-time high date	2021-01-19
All-time low	BRL 1.18
All-time low date	2025-07-30
Average true range (ATR)	BRL 0.48
Average volume	2.2M
Beta (1Y)	-0.43
Beta (2Y)	0.14
Beta (5Y)	0.24
Change from 52-week high	-48.53%
Change from 52-week low	91.03%
Change from all-time high	-98.76%
Change from all-time low	153.39%
Change from open	-6.88%
Day's gap	0.95%
Dollar volume	BRL 5.7M
High price	BRL 3.31
Low price	BRL 2.96
Monthly RSI	43.22
Open price	BRL 3.20
Position in 52-week range	5.71%
Previous close	BRL 3.17
Price vs 150-day SMA	-4.2%
Price vs 20-day SMA	-33.39%
Price vs 200-day SMA	-10.18%
Price vs 50-day SMA	-15.54%
Relative volume	0.89
RSI	37.6
Sharpe ratio	1.26
Sharpe ratio (3Y)	-0.18
Sharpe ratio (5Y)	-0.45
Sortino ratio	1.87
Sortino ratio (3Y)	-0.18
Sortino ratio (5Y)	-0.56
Volume	1.9M
Weekly RSI	47.28
YTD price change	-34.14%
YTD total return	-34.14%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1.2B
Shares change (QoQ)	0%
Shares change (YoY)	-16.2%
Shares held by insiders	5.97%
Shares held by institutions	86.43%
Shares outstanding	1.2B

Deeper analysis on BVMF/DASA3

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BVMF/DASA3 report

Is a complete BVMF/DASA3 research report available?

No complete published report is available for bvmf/DASA3 (BVMF/DASA3) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BVMF/DASA3 (BVMF/DASA3)

Price

Financial snapshot

Fair-value bridge

Latest news · BVMF/DASA3

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BVMF/DASA3 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BVMF/DASA3

Frequently asked questions